Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib (STIM 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01343173
Recruitment Status : Completed
First Posted : April 27, 2011
Last Update Posted : March 13, 2018
Sponsor:
Information provided by (Responsible Party):
University Hospital, Bordeaux

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 30, 2017
Actual Study Completion Date : May 30, 2017